MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CYCN — Cyclerion Therapeutics, Inc. Common Stock
NasdaqCyclerion Therapeutics, Inc. Common Stock
$23.52
-6.23(-20.94%)
- O
- 26.04
- H
- 26.88
- L
- 19.74
- V
- 62.49K
⏱️ End-of-day dataAs of Sep 8, 2026
Chart
About CYCN
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMar 18, 2019
Employees1
Stock ExchangeNasdaq
Ticker SymbolCYCN
Websitehttps://www.cyclerion.com
Key Financial Statistics
| Market Cap | $16.71M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.03 - $36.33 |
| 52-Week Avg Volume | 1.75M |
| VWAP | $23.24 |
| Transactions | 3,387 |
| Total Recorded Bars | 1,881 days |